REGULATED PRESS RELEASE
News
-
-
REGULATED PRESS RELEASE
Biophytis met en lumière son approche innovante du traitement de l’obésité lors d’une présentation majeure au congrès ECO 2025
Biophytis met en lumière son approche innovante du traitement de l'obésité lors d'une présentation majeure au congrès ECO 2025. Le Dr Serge Camelo présente les dernières données du programme clinique OBA sur BIO101 pour limiter la perte musculaire chez les patients obèses -
REGULATED PRESS RELEASE
Biophytis Highlights Innovative Approach to Obesity Treatment During Key ECO 2025 Presentation
Biophytis highlights innovative approach to obesity treatment at ECO 2025 presentation, showcasing promising results of BIO101 drug candidate targeting muscle loss in obese patients -
-
-
-
-
PRESS RELEASE
TAG Immobilien AG successfully starts into 2025; strong operating cash flow drives further NTA growth and reduces LTV to near target level
TAG Immobilien AG reports successful start in 2025 with strong cash flow and reduced LTV, achieving NTA growth. Rental income and EBITDA show positive trends -
PRESS RELEASE
2024/2025 financial year: HBM Healthcare achieved profit of CHF 19 million in a challenging environment
HBM Healthcare Investments AG achieved a profit of CHF 19 million in the 2024/2025 financial year despite challenging conditions. Net asset value per share rose by 1.5% while the share price declined by -2.6% -
PRESS RELEASE
Avolta reports strong first quarter 2025, with CORE turnover growth of +8.2% CER, EBITDA margin of 6.4%, +37bps YoY, and reaffirms outlook
Avolta AG reports a strong first quarter 2025 with +8.2% CORE turnover growth and 6.4% EBITDA margin. The company reaffirms outlook and medium-term targets
